PRESS RELEASE published on 04/20/2023 at 18:00, 3 years ago BIOSYNEX SA: RESULTATS ANNUELS 2022 - POURSUITE DU PLAN DE TRANSFORMATION EN 2023
PRESS RELEASE published on 04/13/2023 at 18:00, 3 years ago BIOSYNEX SA: PROLONGATION DE LA PERIODE D’OFFRE PUBLIQUE D’ACHAT SUR LES TITRES DE CHEMBIO DIAGNOSTICS INC.
PRESS RELEASE published on 04/05/2023 at 18:00, 3 years 1 month ago BIOSYNEX SA: DÉCLARATION DU NOMBRE D’ACTIONS ET DES DROITS DE VOTE AU 31 MARS 2023
PRESS RELEASE published on 03/29/2023 at 18:00, 3 years 1 month ago BIOSYNEX SA: PROLONGATION DE LA PERIODE D’OFFRE PUBLIQUE D’ACHAT SUR LES TITRES DE CHEMBIO DIAGNOSTICS INC.
PRESS RELEASE published on 03/15/2023 at 18:00, 3 years 1 month ago BIOSYNEX SA: PROLONGATION DE LA PERIODE D’OFFRE PUBLIQUE D’ACHAT SUR LES TITRES DE CHEMBIO DIAGNOSTICS INC.
PRESS RELEASE published on 03/09/2023 at 18:05, 3 years 1 month ago BIOSYNEX SA: ARRET DE LA COMMERCIALISATION DE BOUILLOTTES
PRESS RELEASE published on 02/08/2023 at 08:00, 3 years 3 months ago BIOSYNEX SA: DESCRIPTIF DU PROGRAMME DE RACHAT D’ACTIONS
PRESS RELEASE published on 02/01/2023 at 18:30, 3 years 3 months ago BIOSYNEX SA: ANNONCE DES RESULTATS DEFINITIFS DE L’OPA DE BIOSYNEX SUR LES ACTIONS THERADIAG
PRESS RELEASE published on 01/31/2023 at 23:00, 3 years 3 months ago BIOSYNEX SA: BIOSYNEX ET CHEMBIO DIAGNOSTICS ANNONCENT UN ACCORD DEFINITIF D’ACQUISITION
PRESS RELEASE published on 01/19/2023 at 18:00, 3 years 3 months ago BIOSYNEX SA: CHIFFRE D’AFFAIRES 2022 CONFORME AUX ANTICIPATIONS
Published on 05/09/2026 at 00:00, 39 minutes ago Onco-Innovations Progresses Toward IND Preparation as Nucro-Technics Commences Bioanalysis for PNKP Inhibitor Technology
Published on 05/08/2026 at 23:00, 1 hour 39 minutes ago Digi Power X Announces Upsizing of At-the-Market Offering Program
Published on 05/08/2026 at 22:30, 2 hours 9 minutes ago Integrated BioPharma Reports Results for its Quarter Ended March 31, 2026
Published on 05/08/2026 at 22:30, 2 hours 9 minutes ago Sekur Private Data Advances Defense-Grade Secure Communications Platform
Published on 05/08/2026 at 20:38, 4 hours 1 minute ago EQS-Adhoc: thyssenkrupp nucera AG & Co. KGaA: Preliminary Figures for Q2/6M 2025/26; Order Intake Above Expectations and Previous Year ; Sales and Earnings below Market Expectations
Published on 05/08/2026 at 19:12, 5 hours 26 minutes ago EQS-Adhoc: Viromed Medical AG missed revenue forecast for 2025 financial year, but continued to grow significantly and achieved a positive result; revised forecast for 2026
Published on 05/08/2026 at 19:02, 5 hours 37 minutes ago Metall Zug – Annual General Meeting of Shareholders approves all proposals
Published on 05/07/2026 at 19:15, 1 day 5 hours ago 2026 Annual General Meeting: approval of all resolutions submitted to the Meeting
Published on 05/07/2026 at 19:15, 1 day 5 hours ago Assemblée Générale annuelle 2026 : approbation de l’ensemble des résolutions soumises au vote
Published on 05/07/2026 at 19:06, 1 day 5 hours ago Disclosure of Share Capital and Voting Rights as of April 30, 2026
Published on 05/07/2026 at 19:06, 1 day 5 hours ago Déclaration du nombre d’actions et droits de vote au 30 avril 2026
Published on 05/07/2026 at 19:00, 1 day 5 hours ago ALTAREIT - INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
